Trials (East Tallinn Central Hospital): Revision history

6 December 2025

• curprev 12:4012:40, 6 December 2025‎ Lucas talk contribs‎ m 36,026 bytes +1,701‎ Update categories. undo

2 December 2025

• curprev 16:3516:35, 2 December 2025‎ Francine talk contribs‎ 34,325 bytes +7‎ No edit summary undo
• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 34,318 bytes +5,559‎ Update categories. undo

5 November 2024

• curprev 23:4123:41, 5 November 2024‎ Victor talk contribs‎ 28,759 bytes +12‎ No edit summary undo

24 June 2024

• curprev 16:4216:42, 24 June 2024‎ Victor talk contribs‎ 28,747 bytes −7‎ No edit summary undo

4 January 2024

• curprev 14:4114:41, 4 January 2024‎ Francine talk contribs‎ 28,754 bytes +78‎ No edit summary undo
• curprev 14:4014:40, 4 January 2024‎ Francine talk contribs‎ 28,676 bytes +2‎ No edit summary undo
• curprev 14:3914:39, 4 January 2024‎ Francine talk contribs‎ 28,674 bytes −79‎ No edit summary undo
• curprev 14:3814:38, 4 January 2024‎ Francine talk contribs‎ 28,753 bytes +570‎ No edit summary undo

1 December 2023

• curprev 20:3920:39, 1 December 2023‎ Francine talk contribs‎ 28,183 bytes +28,183‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t..."